Skip to main content
Search

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Discovery of a new way for our brain cells to communicate

Published on: 09/09/2021 Reading time: 1 min
Discovery of a new way for our brain cells to communicate
Retour à la recherche

A study conducted by Anne Desmazières, Rémi Ronzano and Thomas Roux in Catherine Lubetzki’s team at Paris Brain Institute, shows for the first time a new interaction between neurons and microglia, immune cells present in the brain. This hitherto unknown mode of communication could be key to a better understanding of brain repair mechanisms and pathologies such as multiple sclerosis. The results are published in Nature Communications.

In our nervous system, the transmission of nerve impulses (nerve messages) takes place via the extensions of neurons, the axons, surrounded by an insulating sheath called myelin. The nodes of Ranvier, small domains interspersed between the myelin segments, are essential for the rapid diffusion of information, but they are also a hub of cellular interactions in the brain.

Previous studies have already shown that certain types of brain cells, such as oligodendrocytes and astrocytes, form contacts with neurons at these nodes of Ranvier. However, interactions with another essential brain cell type, microglia, had not been explored. These immune cells play a key role in protecting the brain and in regenerative processes such as remyelination, the reformation of the myelin sheath, which is affected in diseases such as multiple sclerosis.

A study conducted at the Paris Brain Institute by Anne Desmazières and her colleagues Rémi Ronzano and Thomas Roux in Catherine Lubetzki's team shows for the first time that contacts and communication exist between neurons and microglial cells at the level of the nodes of Ranvier.

Thanks to studies carried out on ex-vivo (tissue culture) and in-vivo mouse models, in particular using real-time imaging approaches to observe the dynamics of these contacts, but also on human tissue, the researchers revealed a particularly stable interaction between these two types of cells, and a reinforced dialogue in a context of myelin regeneration. They also identified the mechanisms underlying this dialogue. Neuronal activity mediates and reinforces the interaction. Microglia are able to 'read' the information arriving at the nodes of Ranvier in the form of an ionic signal, thus modulating their state and their interaction with the neuron. Alteration of this ionic signal can keep microglia in a pro-inflammatory state, preventing them from playing their pro-regenerative and pro-remyelinating role.

In the case of multiple sclerosis, this discovery opens up several avenues of research to better understand the disease, in particular the impact of inflammatory signals in this disease on the neuron-microglia dialogue and the pro-remyelinating potential of microglia. The discovery of this dialogue is all the more interesting as therapies being tested in multiple sclerosis are now trying to act on the physiology of these microglia in order to promote their pro-regenerative character.

This new mode of communication also raises the question of the impact of neuronal activity on the behaviour of microglia. Indeed, many neurological pathologies, including epilepsy, are associated with alterations in neuronal activity, and the consequences of this alteration on microglial cells are still unknown.

Sources

Microglia-neuron interaction at nodes of Ranvier depends on neuronal activity through potassium release and contributes to remyelination. Ronzano R, Roux T, Thetiot M, Aigrot MS, Richard L, Lejeune FX, Mazuir E, Vallat JM, Lubetzki C, Desmazières A.Nat Commun. 2021 Se

Our news on the subject

Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
See all our news